These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

840 related articles for article (PubMed ID: 31915054)

  • 21. Momordica charantia Administration Improves Insulin Secretion in Type 2 Diabetes Mellitus.
    Cortez-Navarrete M; Martínez-Abundis E; Pérez-Rubio KG; González-Ortiz M; Méndez-Del Villar M
    J Med Food; 2018 Jul; 21(7):672-677. PubMed ID: 29431598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of
    Zhang X; Zhao Y; Song Y; Miao M
    Heliyon; 2024 May; 10(10):e31126. PubMed ID: 38784554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effectiveness of glucagon-like peptide-1 receptor agonists on body composition and anthropometric indices: A protocol for a systematic review and network meta-analysis of randomized controlled trials.
    Wachiraphansakul N; Vongchaiudomchoke T; Manosroi W; Nochaiwong S
    PLoS One; 2024; 19(2):e0297488. PubMed ID: 38408098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging Trends On Drug Delivery Strategy of Momordica charantia against Diabetes and its Complications.
    Thent ZC; Das S; Zaidun NH
    Curr Drug Deliv; 2018; 15(4):453-460. PubMed ID: 28545355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice.
    Miura T; Itoh C; Iwamoto N; Kato M; Kawai M; Park SR; Suzuki I
    J Nutr Sci Vitaminol (Tokyo); 2001 Oct; 47(5):340-4. PubMed ID: 11814149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice.
    Wang HY; Kan WC; Cheng TJ; Yu SH; Chang LH; Chuu JJ
    Food Chem Toxicol; 2014 Jul; 69():347-56. PubMed ID: 24751968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vivo Treatment Efficacy of Essential Oil Isolated from Seeds of Momordica charantia in Streptozotocin-Induced Diabetes Mellitus.
    Mariammal BGV; Devarajan DW; Jerrin R; Viswanathan S; Siddikuzzaman ; Gopal R
    Recent Pat Biotechnol; 2021; 15(4):316-331. PubMed ID: 34515016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients.
    Fuangchan A; Sonthisombat P; Seubnukarn T; Chanouan R; Chotchaisuwat P; Sirigulsatien V; Ingkaninan K; Plianbangchang P; Haines ST
    J Ethnopharmacol; 2011 Mar; 134(2):422-8. PubMed ID: 21211558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of antidiabetic effects of saponins and polysaccharides from Momordica charantia L. in STZ-induced type 2 diabetic mice.
    Wang Q; Wu X; Shi F; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():744-750. PubMed ID: 30551527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoglycaemic and hypotensive effects of Momordica charantia Linn (Cucurbitaceae) whole-plant aqueous extract in rats.
    Ojewole JA; Adewole SO; Olayiwola G
    Cardiovasc J S Afr; 2006; 17(5):227-32. PubMed ID: 17117226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effectiveness of sodium-glucose co-transporter 2 inhibitors for controlling hyperglycaemia in patients with type 2 diabetes: protocol for a systematic review and network meta-analysis.
    Chen M; Xie CG; Gao H; Zheng H; Chen Q; Fang JQ
    BMJ Open; 2016 Jan; 6(1):e010252. PubMed ID: 26826156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing effects of continuous glucose monitoring systems (CGMs) and self-monitoring of blood glucose (SMBG) amongst adults with type 2 diabetes mellitus: a systematic review protocol.
    Zheng M; Luo Y; Lin W; Khoja A; He Q; Yang S; Zhao X; Hu P
    Syst Rev; 2020 May; 9(1):120. PubMed ID: 32475343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis.
    Ambachew S; Eshetie S; Geremew D; Endalamaw A; Melku M
    Syst Rev; 2019 Feb; 8(1):60. PubMed ID: 30803444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and safety of self-management interventions among adult type 2 diabetes mellitus patients in sub-Saharan Africa: a systematic review protocol.
    Carter N; Chahal P; Chattopadhyay K
    JBI Evid Synth; 2022 Jan; 20(1):204-213. PubMed ID: 34324467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the efficacy of bitter gourd (momordica charantia) as an oral hypoglycemic agent--a randomized controlled clinical trial.
    John AJ; Cherian R; Subhash HS; Cherian AM
    Indian J Physiol Pharmacol; 2003 Jul; 47(3):363-5. PubMed ID: 14723327
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effectiveness of phytotherapy in supportive treatment of type 2 diabetes mellitus III. Momordica (Momordica charantia)].
    Rudá-Kučerová J; Kotolová H; Koupý D
    Ceska Slov Farm; 2015 Sep; 64(4):126-32. PubMed ID: 26459126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Momordica charantia reverses type II diabetes in rat.
    Malekshahi H; Bahrami G; Miraghaee S; Ahmadi SA; Sajadimajd S; Hatami R; Mohammadi B; Keshavarzi S
    J Food Biochem; 2019 Nov; 43(11):e13021. PubMed ID: 31441956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioactive scaffolds in stem-cell-based therapies for cardiac repair: protocol for a meta-analysis of randomized controlled preclinical trials in animal myocardial infarction models.
    Khan K; Gasbarrino K; Mahmoud I; Makhoul G; Yu B; Dufresne L; Daskalopoulou SS; Schwertani A; Cecere R
    Syst Rev; 2018 Dec; 7(1):225. PubMed ID: 30518435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of walking exercise on glycemic control in patients with type 2 diabetes mellitus: A protocol for systematic review and meta-analysis of randomized cross-over controlled trials.
    Hu H; Lei Y; Yin L; Luo X
    Medicine (Baltimore); 2020 Nov; 99(47):e22735. PubMed ID: 33217794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: protocol for a systematic review and network meta-analysis.
    Tricco AC; Ashoor HM; Soobiah C; Hemmelgarn B; Moher D; Hutton B; Yu CH; Majumdar SR; Straus SE
    Syst Rev; 2013 Sep; 2():73. PubMed ID: 24020869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.